Table 4.
Question | Answers | van der Kolk 201114 | Kim 201215 | Skarpathiotakis 201316 | Vakil 201317 | Qiao 201418 | Teng 201519 | Xu 201520 | Zou 201521 |
---|---|---|---|---|---|---|---|---|---|
Was the study sample prospectively selected to minimize the risk of selection bias? | Yes (+) or no (−) | + | + | − | − | + | + | + | + |
Were the inclusion and exclusion criteria adequately described? | Yes (+) or no (−) | + | + | + | + | + | + | + | + |
Was the study's primary objective to assess whether enhancement was associated with ischemic presentations? | Yes (+) or no (−) | − | + | + | + | + | + | + | + |
Were the investigators blinded to the location of infarction during vessel wall enhancement detection? | Yes (+) or no (−) | − | + | + | + | + | + | + | + |
Did more than 1 investigator assess for the presence of vessel enhancement? | Yes (+) or no (−) | + | + | − | + | + | + | + | + |
Was a measure of interreader reproducibility for enhancement detection reported? | Yes (+) or no (−) | − | − | − | + | + | − | − | − |
Did more than 1 investigator adjudicate culprit lesion detection? | Yes (+) or no (−) | − | − | − | − | + | − | − | − |
Were culprit and nonculprit lesions matched in terms of vessel stenosis severity? | Yes (+) or no (−) | − | − | − | − | − | − | − | − |
Note: If data not provided or not specified, recorded as no (−).